Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor

  • Read more about Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor
Canada
2902423
Filed on 2013-04-30

Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor

  • Read more about Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor
Australia
2013379772
Filed on 2013-04-30

ANTI-CD276 ANTIBODIES (B7H3)

  • Read more about ANTI-CD276 ANTIBODIES (B7H3)
Patent Cooperation Treaty
PCT/US2015/050365
Filed on 2015-09-16

Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis

  • Read more about Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis
Patent Cooperation Treaty
PCT/US15/047538
Filed on 2015-08-28

Human Monoclonal Antibodies That Bind Insulin-Like Growth Factor (IGF) I and II

  • Read more about Human Monoclonal Antibodies That Bind Insulin-Like Growth Factor (IGF) I and II
US Patent 9,676,846
Filed on 2015-08-21

Tetrahydroxamate Chelators of Zirconium89 and Niobium90 for Use in Diagnostic Applications

  • Read more about Tetrahydroxamate Chelators of Zirconium89 and Niobium90 for Use in Diagnostic Applications
US Patent 10,137,212
Filed on 2015-09-11

TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications

  • Read more about TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications
European Patent
14779019.0
Filed on 2014-03-12

Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use

  • Read more about Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use
US Patent 10,047,122
Filed on 2015-09-14

METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS

  • Read more about METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS
Canada
2897828
Filed on 2015-07-21

Vascular Endothelial Growth Factor Antagonist And Methods For Their Use

  • Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use
Hong Kong
15105159.9
Filed on 2015-05-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 635
  • Page 636
  • Page 637
  • Page 638
  • Page 639
  • Page 640
  • Page 641
  • Page 642
  • Page 643
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health